论文部分内容阅读
应用改进的白细胞移动抑制试验测试不同类型肝炎患者的细胞免疫状态。以植物血凝素(PHA)为刺激因子,133名迁肝患者中有53.4％,18例慢活肝患者中有72.2％,12例急性肝炎患者中有50％呈现白细胞移动抑制,而27名健康人均出现抑制现象。以粗制乙型肝炎表面抗原(HBsAg)为抗原,在79例肝炎患者中,有77.2％出现异常反应,而在25名健康人中只有4％为阳性。以肝细胞膜脂蛋白(LPI)为抗原,133例迁肝中有18.1％,18例慢活肝中有44.4％,12例急性肝炎中有25.0％呈异常反应,而在32名健康人中只有3.1％异常。
The improved leukocyte migration inhibition test was used to test the cellular immune status of patients with different types of hepatitis. With phytohaemagglutinin (PHA) as a stimulating factor, 53.4% of 133 patients with hepatic relocation and 72.2% of 18 patients with chronic liver disease showed leukocyte migration inhibition in 50% of 12 patients with acute hepatitis, while 27 Inhibition of health per capita appear. With crude hepatitis B surface antigen (HBsAg) as an antigen, 77.2% of 79 hepatitis patients showed abnormal reactions, while only 4% of 25 healthy people were positive. Using LPI as antigen, 18.1% of 133 patients migrated to liver, 44.4% of 18 patients died of chronic hepatitis, and 25.0% of 12 patients showed abnormal reaction. Among 32 healthy persons, only 3.1% abnormal.